Join Gary, Kate, Mark and Henry as they discuss text messages for adolescent vaping cessation, stopping BP meds in nursing home residents with dementia, the benefits of SGLT-2 inhibitors, and mobile phone app–based artificial intelligence for diagnosing melanoma.
Click <a href="https://docs.google.com/document/d/1ctJlNp7Ud4srAFYFnif0q6Y9hxYNtTaqaI1xFC94RZk/edit?usp=sharing" target="_blank" rel="ugc noopener noreferrer">here</a> for transcript, notes and links for this episode.

Join Gary, Kate, Mark and Henry as they discuss text messages for adolescent vaping cessation, stopping BP meds in nursing home residents with dementia, the benefits of SGLT-2 inhibitors, and mobile phone app–based artificial intelligence for diagnosing melanoma. Click here for transcript, notes and links for this episode.

Join Gary, Kate, Mark and Henry as they discuss text messages for adolescent vaping cessation, stopping BP meds in nursing home residents with dementia, the benefits of SGLT-2 inhibitors, and mobile phone app–based artificial intelligence for diagnosing melanoma.
Click <a href="https://docs.google.com/document/d/1ctJlNp7Ud4srAFYFnif0q6Y9hxYNtTaqaI1xFC94RZk/edit?usp=sharing" rel="noopener noreferrer">here</a> for transcript, notes and links for this episode.

Episode 166: vaping cessation, BP meds and dementia, SGLT-2's, and AI for melanoma

Four healthily skeptical primary care physicians discuss the latest in primary care medicine. Join Essential Evidence Editor Mark Ebell MD, Rush University's Kate Rowland MD, MSU Professor of Medicine Gary Ferenchick MD, and POEMs co-founder Henry Barry MD, MS for this fast-paced weekly update on evidence-based primary care.

Share Episode 166: vaping cessation, BP meds and dementia, SGLT-2's, and AI for melanoma

Sign up to save your podcasts

Episode 166: vaping cessation, BP meds and dementia, SGLT-2's, and AI for melanoma

Episode 166: vaping cessation, BP meds and dementia, SGLT-2's, and AI for melanoma